Our 27th annual Advances in Autism Conference will be hosted on Tuesday, May 23, 2023. This virtual event can be attended from anywhere online.
Established in 1996, the conference brings together academic, parent and community groups to participate in thoughtful and informative presentations. The goals of the event are to discuss recent advances in autism – the causes, symptoms, and current and future treatments.
The focus of the 2023 Advances in Autism Conference is Precision Medicine in Profound Autism.
International studies led by the Director of the Seaver Autism Center, Joseph D. Buxbaum, PhD, and colleagues, have identified more than 200 genes that, if changed, strongly contribute to autism. These discoveries also show that at least 25% of individuals with profound autism have genetic mutations.
Clinical researchers are now shifting their focus on treatments for autism. Rather than treating all autism as a single entity, we can now begin to look at genetically determined subtypes of autism, and consider treatments that are tailored to the genetic subtype. This approach, called precision medicine, has revolutionized cancer treatment, and will revolutionize the treatment of profound autism.
Attend the conference to learn how researchers are identifying genetic mutations in autism, how the mutations lead to biologically-determined subtypes of autism, and how preclinical and clinical research are developing and testing new treatments for these subtypes. The interactions between academic scientists, families and advocacy groups, and industry partners will also be discussed, as precision medicine requires input from all these groups.
Joseph D. Buxbaum, PhD
Genetics-First Approaches to Therapeutics in Autism
Nael Nadif Kasri, PhD
Modelling Neurodevelopmental Disorders in a Dish
William J. Polvino, MD
New Drug Development in the Pharmaceutical Industry
Rachel Groth, PhD
Building a Pharmaceutical Industry, Academia, and Patient Advocacy Ecosystem for the Efficient Development of Therapeutics
Alex Kolevzon, MD
Predicting Treatment Response to Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism
Tim W. Yu, MD, PhD
Milestones on the Path Towards Genetic Interventions for Autism
Jeffrey Neul, MD PhD
Rett Syndrome, from Gene Discovery to First Approved Treatment: Opportunities and Challenges for Future Clinical Trial
Visit our past events page to learn more about previous conferences.